SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,758,000 | +2.6% | 3,792,000 | 0.0% | 0.02% | -4.0% |
| Q1 2021 | $3,662,000 | +2.2% | 3,792,000 | 0.0% | 0.02% | -3.8% |
| Q4 2020 | $3,583,000 | +2.6% | 3,792,000 | 0.0% | 0.03% | -3.7% |
| Q3 2020 | $3,493,000 | +4.7% | 3,792,000 | 0.0% | 0.03% | 0.0% |
| Q2 2020 | $3,337,000 | +9.6% | 3,792,000 | 0.0% | 0.03% | 0.0% |
| Q1 2020 | $3,045,000 | -11.3% | 3,792,000 | 0.0% | 0.03% | +22.7% |
| Q4 2019 | $3,432,000 | +12.6% | 3,792,000 | +15.2% | 0.02% | +10.0% |
| Q3 2019 | $3,049,000 | -30.6% | 3,292,000 | -26.8% | 0.02% | -28.6% |
| Q2 2019 | $4,391,000 | – | 4,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
| Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
| DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
| AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |